BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 3937341)

  • 1. Specific desensitization of the canine renal vasculature to angiotensin II despite cyclo-oxygenase inhibition.
    Meggs LG; Katzberg RW; DeLeeuw P; Hollenberg NK
    Yale J Biol Med; 1985; 58(5):453-8. PubMed ID: 3937341
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Renal vascular tachyphylaxis to angiotensin II: specificity of the response for angiotensin.
    de Leeuw PW; Meggs LG; Hollenberg NK
    Life Sci; 1982 Mar; 30(10):813-9. PubMed ID: 7070197
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of cyclooxygenase and thromboxane synthase inhibition on the response to angiotensin II in the hypoperfused canine kidney.
    Goto F; Jackson EK; Ohnishi A; Herzer W; Branch RA
    J Pharmacol Exp Ther; 1987 Dec; 243(3):799-803. PubMed ID: 3121844
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of altered sodium balance upon renal vascular reactivity to angiotensin II and norepinephrine in the dog. Mechanism of variation in angiotensin responses.
    Oliver JA; Cannon PJ
    J Clin Invest; 1978 Mar; 61(3):610-23. PubMed ID: 641142
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of renal nerve stimulation, norepinephrine and angiotensin II on renal blood flow in relation to release of PG-like substances in anesthetized dogs.
    Satoh S; Ohyama Y; Hayashi M
    Arch Int Pharmacodyn Ther; 1981 Dec; 254(2):304-16. PubMed ID: 7337502
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intrarenal vascular effects of angiotensin II and angiotensin III in the dog.
    Britton SL; Fiksen-Olsen MJ; Houck PC; Romero JC
    J Hypertens; 1983 Jun; 1(1):95-101. PubMed ID: 6681031
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effects of indomethacin on renal and uterine blood flow and pressor responsiveness to angiotensin II or norepinephrine in pregnant dogs].
    Matsuura S; Sanda Y; Kubo K; Tamai T; Sagawa N
    Nihon Sanka Fujinka Gakkai Zasshi; 1983 Dec; 35(12):2349-58. PubMed ID: 6663143
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Attenuation by arachidonic acid of the effect of vasoconstrictor stimuli in the canine kidney.
    Susić H; Malik KU
    J Pharmacol Exp Ther; 1981 Nov; 219(2):377-82. PubMed ID: 6793715
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of adenosine A(1) receptor in angiotensin II- and norepinephrine-induced renal vasoconstriction.
    Aki Y; Nishiyama A; Miyatake A; Kimura S; Kohno M; Abe Y
    J Pharmacol Exp Ther; 2002 Oct; 303(1):117-23. PubMed ID: 12235241
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Facilitation of adrenergic transmission in the canine heart by intracoronary infusion of angiotensin II: effect of prostaglandin synthesis inhibition.
    Lanier SM; Malik KU
    J Pharmacol Exp Ther; 1983 Dec; 227(3):676-82. PubMed ID: 6317843
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Conjugate effects of saralasin and indomethacin on kidney function in anesthetized dog.
    Tost H; Kövér G; Darvasi A
    Acta Physiol Hung; 1995; 83(1):63-77. PubMed ID: 7660839
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparison of the vasoconstrictor effects of angiotensin II and angiotensin III in the canine renal vasculature.
    Satoh S; Itsukaichi O; Ohyama Y; Hayashi M
    Arch Int Pharmacodyn Ther; 1981 Jun; 251(2):301-9. PubMed ID: 7283551
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of des-aspartate-angiotensin I on the actions of angiotensin II in the isolated renal and mesenteric vasculature of hypertensive and STZ-induced diabetic rats.
    Dharmani M; Mustafa MR; Achike FI; Sim MK
    Regul Pept; 2005 Jul; 129(1-3):213-9. PubMed ID: 15927718
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the vasodilatory effects of bradykinin in isolated dog renal arteries and in buffer-perfused dog kidneys.
    Malomvölgyi B; Hadházy P; Tekes K; Koltai MZ; Pogátsa G
    Acta Physiol Hung; 1996; 84(1):9-18. PubMed ID: 8993670
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adrenomedullin inhibits the pressor effects and decrease in renal blood flow induced by norepinephrine or angiotensin II in anesthetized rats.
    Minami K; Segawa K; Uezono Y; Shiga Y; Shiraishi M; Ogata J; Shigematsu A
    Jpn J Pharmacol; 2001 Jun; 86(2):159-64. PubMed ID: 11459117
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Angiotensin II and norepinephrine after indomethacin in isolated perfused canine kidneys. Tachyphylaxis vs. modulator effect of prostaglandins.
    Ellis B; Itskovitz HD
    Prostaglandins; 1980 Dec; 20(6):981-91. PubMed ID: 7010451
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Demonstration of the existence of nitric oxide-independent as well as nitric oxide-dependent vasodilator mechanisms in the in situ renal circulation in near term pregnant rats.
    Chu ZM; Beilin LJ
    Br J Pharmacol; 1997 Sep; 122(2):307-15. PubMed ID: 9313940
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential effects of endotoxaemia on pressor and vasoconstrictor actions of angiotensin II and arginine vasopressin in conscious rats.
    Tarpey SB; Bennett T; Randall MD; Gardiner SM
    Br J Pharmacol; 1998 Apr; 123(7):1367-74. PubMed ID: 9579732
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacological evaluation in conscious dogs of factors involved in the renal vasodilator effect of captopril.
    Wong PC; Zimmerman BG; Kraft E; Kounenis G; Friedman P
    J Pharmacol Exp Ther; 1981 Dec; 219(3):646-50. PubMed ID: 7028950
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of calcium membrane blockers on in vivo vasoconstrictor properties of norepinephrine, angiotensin II and vasopressin.
    Goldberg JP; Schrier RW
    Miner Electrolyte Metab; 1984; 10(3):178-83. PubMed ID: 6727804
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.